09.08.2022 | Letter to the Editor
Effective treatment with polatuzumab vedotin of relapsed and refractory primary cutaneous diffuse large B-cell lymphoma leg type
Erschienen in: Annals of Hematology | Ausgabe 10/2022
Einloggen, um Zugang zu erhalten